Hennion & Walsh Asset Management, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
Shares
12 transactions
Others Institutions Holding KNSA
# of Institutions
156Shares Held
40.3MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$89 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$68 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$66.6 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$63.3 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$59.6 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $732M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...